Ignoring drug costs risks NHS 'crash', NICE warns

Approving expensive new treatments without regard to cost would be a 'huge risk' for the NHS, NICE's chairman has said.

NICE: NHS cannot afford unsustainable prices for new drugs (photo: Jason Heath Lancy)
NICE: NHS cannot afford unsustainable prices for new drugs (photo: Jason Heath Lancy)

Professor David Haslam, former RCGP chairman and president, defended NICE's decision-making on new drugs, saying it was 'an inescapable and global truth that funding for healthcare is limited'.

Professor Haslam also questioned why drug development costs are so high.

NICE has faced years of criticism over decisions not to approve new treatments based on high cost.

The government set up the Cancer Drug Fund in 2011 to give patients access to treatments blocked or yet to be evaluated by NICE. The scheme has been extended to 2016.

Speaking at the NICE annual conference in Birmingham on Tuesday, Professor Haslam said patients in other countries may have access to 'hugely expensive' treatments blocked by NICE.

'Huge risk'

But cancer patients in the US are two-and-a-half times more likely to declare bankruptcy than the rest of the population, he argued. 'Isn't bankruptcy as much a side-effect of that treatment as nausea?'

He went on: 'You can only ignore real costs if you're not dealing with real money. Real money is spent by someone. Once spent, it's not available to be spent on something else.

'If it's patients who end up bankrupt, or healthcare systems that cannot afford to offer care equitably, because of huge expense in one particular area of care, that ignoring fiscal value as well as clinical value carries huge risk, to patients as well as systems.

'If we keep paying unsustainable prices, what happens? Something's bound to crash.'

Professor Haslam questioned the cost of new drug development. 'Why is it so expensive? It seems to me currently no one really knows, outside the board of a pharma firm, how it evaluates a drug's cost.

'I think if we can understand more about this, it would be of real benefit.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

30,000 GPs face uncertainty over pension tax risk for 2017/18

30,000 GPs face uncertainty over pension tax risk for 2017/18

More than 30,000 GPs do not know if they will face pension tax charges for 2017/18...

NHS 'rapid response' teams must not drive up GP workload, warns BMA

NHS 'rapid response' teams must not drive up GP workload, warns BMA

NHS 'rapid response' teams being rolled out from April to help older people avoid...

Councils demand transformation of London's ageing GP surgeries

Councils demand transformation of London's ageing GP surgeries

Council leaders in London are calling for a transformation of the capital’s 'ageing...

GP demand greater focus on underdoctored areas as access inequalities grow

GP demand greater focus on underdoctored areas as access inequalities grow

GP leaders have called for a greater focus on recruitment to underdoctored areas...

Draft PCN plans put practices' financial stability at risk, say London GPs

Draft PCN plans put practices' financial stability at risk, say London GPs

Draft service specifications for primary care networks (PCNs) threaten the stability...

One in six GP practices linked to parkrun events

One in six GP practices linked to parkrun events

More than 1,350 GP practices across the UK have linked up with a local parkrun event...